Marker Therapeutics (MRKR) Insider Trading & Ownership $3.34 -0.15 (-4.30%) (As of 05:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Marker Therapeutics (NASDAQ:MRKR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.35%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.81 MNumber OfInsiders Selling(Last 12 Months)0 Get MRKR Insider Trade Alerts Want to know when executives and insiders are buying or selling Marker Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRKR Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.>> Register for the Workshop Now Marker Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2024Enterprise Associates 16 NewMajor ShareholderBuy554,250$3.20$1,773,600.00 12/23/2024Steve ElmsDirectorBuy11,085$3.20$35,472.00 (Data available from 1/1/2013 forward) MRKR Insider Trading Activity - Frequently Asked Questions Who is on Marker Therapeutics's Insider Roster? The list of insiders at Marker Therapeutics includes Enterprise Associates 16 New, Norman David Eansor, and Steve Elms. Learn more on insiders at MRKR. What percentage of Marker Therapeutics stock is owned by insiders? 17.35% of Marker Therapeutics stock is owned by insiders. Learn more on MRKR's insider holdings. Which Marker Therapeutics insiders have been buying company stock? The following insiders have purchased MRKR shares in the last 24 months: Enterprise Associates 16 New ($1,773,600.00), Norman David Eansor ($249,987.50), and Steve Elms ($35,472.00). How much insider buying is happening at Marker Therapeutics? Insiders have purchased a total of 579,620 MRKR shares in the last 24 months for a total of $2,059,059.50 bought. Marker Therapeutics Key ExecutivesDr. Juan F. Vera M.D. (Age 44)Co-Founder, CEO, President, Treasurer, Secretary & Director Compensation: $399.25kMs. Elizabeth DonnellyDirector of AdministrationDr. Maria-Bernadette Madel (Age 34)Director of Corporate Operations & External Communications Mr. Edmund CheungVice President of Human ResourcesDr. Nadia Agopyan Ph.D.Senior Vice President of Regulatory AffairsDr. Monic Stuart M.D.Chief Medical OfficerPatricia AllisonHead of Clinical OperationsDr. Robert Z. Florkiewicz Sr.Senior Director of Molecular Biology & Virology More Insider Trading Tools from MarketBeat Related Companies Cassava Sciences Insider Selling Cabaletta Bio Insider Selling Protara Therapeutics Insider Selling Alto Neuroscience Insider Selling X4 Pharmaceuticals Insider Selling Acumen Pharmaceuticals Insider Selling Editas Medicine Insider Selling MediciNova Insider Selling INmune Bio Insider Selling ALX Oncology Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to Avoid This page (NASDAQ:MRKR) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
